Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 5, 2007, Pages 635-645

  Swanson, James M ^a   Moyzis, Robert K ^b   McGough, James J ^c   McCracken, James T ^c   Riddle, Mark A ^e   Kollins, Scott H ^f   Greenhill, Laurence L ^d   Abikoff, Howard B ^g   Wigal, Tim ^a   Wigal, Sharon B ^a   Posner, Kelly ^d   Skrobala, Anne M ^d   Davies, Mark ^d   Ghuman, Jaswinder K ^h   Cunningham, Charles ⁱ   Vitiello, Benedetto ^j   Stehli, Annamarie ^a   Smalley, Susan L ^c   Grady, Deborah ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD CELL; CHEEK; CONTROLLED STUDY; DAT1 GENE; DNA DETERMINATION; DRD4 GENE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHARMACOGENETICS; PRESCHOOL CHILD; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SNAP25 GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD, PRESCHOOL; DNA; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TANDEM REPEAT SEQUENCES;

EID: 35848947029     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0076     Document Type: Article

References (33)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington (D.C.): American Psychiatric Association, 1994.
2. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL: Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit/hyperactivity disorder. Mol Psychiatry 5:405-409, 2000.
3. Chang F-M, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK: The world-wide distribution of allele frequencies of the human dopamine D4 receptor locus. Hum Genet 98:91-101, 1996.
4. Collins FS: The case for a US prospective cohort study of genes and environment. Nature 429:475-477, 2004.
5. Cook EH Jr., Stein MA, Krasowski MD, Cow NJ, Olkon DM, Kieffer JE, Leventhal BL: Association of attention deficit disorder and the dopamine trasporter gene. Am J Hum Genet 56:993-998, 1995.
6. Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L, Hollis CP: Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 10:686-98, 2005.
7. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, Flodman P, Spence MA, Schuck S, Swanson JM, Zhang YP, Moyzis RK: Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci USA 99:309-314, 2002.
8. Faraone SV, Perlis RH, Doyle AE, Smoller JN, Goralnick JJ, Holmgren MA, Sklar P: Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323, 2005.
9. Fosella J, Posner MI, Fan J, Swanson JM, Pfaff DW. Attentional phenotypes for the analysis of higher mental function. Scientif World J 2:217-223, 2002.
10. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T: Efficacy and Safety of Immediate-release Methylphenidate Treatment for Preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1284-1293, 2006.
11. Grady DL, Chi HC, Ding YC, Smith M, Wang E, Schuck S, Flodman P, Spence MA, Swanson JM, Moyzis RK: High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry 8:536-545, 2003.
12. Hamarman S, Fossella J, Ulger C, Brimacombe M, Dermody J: Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 14:564-574, 2004.
13. Kaiser R, Tremblay P-B, Roots I, Brockmoller J: Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 35:49-56, 2002.
14. Kirley A, Lowe N, Hawi Z, Mullins C, Daly G, Waldman I, McCarron M, O'Donnell D, Fitzgerald M, Gill M: Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet 121B:50-54, 2003.
15. Kollins S, Greenhill L, Swanson J, Wigal S, Abikoff H, Mc-Cracken J, Riddle M, McGough J, Vitiello B, Wigal T, Skrobala A, Posner K, Ghuman J, Davies M, Cunningham C, Bauzo A: Rationale, Design, and Methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry 45:1275-1283, 2006.
16. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL: Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1:121-124, 1996.
17. Li Dm Sham PC, Owen MJ, He L: Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15:2276-2284, 2006.
18. McCracken JT, Smalley SL, McGough JJ, Crawford L, Del Homme M, Cantor RM, Liu A, Nelson SF: Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5:531-536, 2000.
19. McGough JJ: Attention-deficit/hyperactivity disorder pharmacogenomics, Biol Psychiatry 57:1367-1373, 2005.
20. McGough JJ, McCracken JT, Swanson JM, Riddle M, Kollins SH, Greenhill LL, Abikoff H, Davies M, Chuang S, Wigal TL, Wigal SB, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigana S, Moyzis RK, Vitiello B: Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry, 45:1314-1322, 2006.
21. Mill J, Caspi A, Williams, BS, Craig I, Taylor A, Polo-Torres M, Berridge CW, Poulton R, Moffit TE: Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry, 63:462-469, 2006.
22. Moffit TE, Moffit TE, Caspi A, Rutter M, Silva PA: Sex differences in antisocial behavior: conduct disorder, delinquency, and violence in the Dunedin Longitudinal Study. Cambridge, England, Cambridge University Press, 2001.
23. Schaffer D, Fisher P, Lucas, C: The NIMH diagnostic interview schedule for children version 4.0 (DISC-4.0). New York: Ruane Center for Early Diagnosis, Division of Child Psychiatry, Columbia University, 1996.
24. Santosh P, Taylor E, Swanson JM, Wigal S, Chuang S, Davies M, Greenhill L, Newcorn J, Arnold L, Jenson P, Vitiello B, Elliott G, Hinshaw S, Hechtman L, Abikoff H, Pelham W, Hoza B, Molina B, Wells K, Epstein J, Posner M: Refining the diagnoses of inattention and overreactivity syndromes: a reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clin Neurosci Res 5:304-314, 2005.
25. Sigurdson AJ, Ha M, Consentino M, Franklin T, Haque KA, Qi Y Glaser C, Reid Y, Vaught JB, Bergen AN : Long-term storage and recovery of buccal cell DNA from treated cards. Cancer Epidemiol Biomarkers Prev 15:385-388, 2006.
26. Swanson JM, Wigal S, Greenhill L, Brown R, Waslick B, Lerner M, Williams L, Flynn D, Agler D, Crowley KL, Fineberg E, Regino R, Baren M, Cantwell D: Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatmeant of children with ADHD in a controlled laboratory classroom setting. Psychopharmocol Bull 34:55-60, 1998.
27. Swanson JM, Lerner M, March J, Gresham F: Assessment and intervention for attention-deficit/hyperactivity disorder in the schools: Lessons from the MTA Study. Pediatr Clin N Am 46:993-1009, 1999.
28. Swanson JM, Moyzis R, Fossella J, Fan J, Posner M: Adaptionism and molecular biology: An example based on ADHD. Behav Brain Sci 25:530-531, 2002.
29. Thapar A, O'Donovan M, Owen MJ. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 14:R275-R282, 2006.
30. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Lieberman J, Hitsemann R, Wolf AP: Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463, 1995.
31. Walsh S, Erlich HA, Higuchi, R: Preferential PCR amplification of alleles: Mechanisms and solutions. PCR Methods Applic 1:241-250, 1992.
32. Wang E, Ding YC, Flodman P, Kidd JR, Kidd KK, Grady DL, Ryder OA, Spence MA, Swanson JM, Moyzis RK: The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet 74:931-944, 2004.
33. Wender P: Minimal brain dysfunction in children. Wiley-Liss, New York, 1971.